Quiver Bioscience Secures Non-Dilutive Funding to Enhance CNS Genetic Medicine Drug Discovery Platform Capabilities and Advance Powerful AI/ML-Based In Vitro / In Silico Predictor of CNS Drug ...

The funding will enable Stalicla to advance its autism-focused drug candidates, support asset partnering, prepare for its Series C financing, and cover general corporate activities. This investment in ...

Addex Therapeutics leads CHF 2 million investment in Stalicla to advance precision medicine in neuropsychiatric disorders: Geneva, Switzerland Tuesday, July 1, 2025, 11:00 Hrs [IS ...

HOUSTON, June 30, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform ...

With the new SBIR funding, Quiver will further augment their existing ASO drug development capabilities by applying their platform to better prediction of ASO CNS toxicity using a combination of ...

NIH budget cuts are threatening key medical research programs, shrinking training grants, and leaving young researchers ...

For decades, international researchers have received a small slice of the National Institutes of Health budget. In 2024, out ...

Researchers in Democratic congressional districts stand to have $2.1 billion in NIH grants reinstated, compared to $62 ...

Canceled grants and slashed budgets are disproportionately affecting junior health researchers, dealing a major blow to the ...

Trump’s 2026 budget includes the biggest cuts for scientific research in decades. Here’s why that’s a terrible idea.

Big Beautiful Bill' proposes cuts for National Institutes of Health and National Science Foundation, threatening valuable scientific research in Georgia and nationwide.

An autopsy study of a 45-year-old former U.S. Navy crewman with severe chronic traumatic encephalopathy (CTE) suggested that ...